HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Joshua Gustine Selected Research

A 419259

1/2022A new role for the SRC family kinase HCK as a driver of SYK activation in MYD88 mutated lymphomas.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Joshua Gustine Research Topics

Disease

6Waldenstrom Macroglobulinemia (Macroglobulinemia)
01/2021 - 01/2017
3Lymphoma (Lymphomas)
01/2022 - 11/2016
2Bone Marrow Diseases (Bone Marrow Disease)
01/2021 - 05/2017
2Disease Progression
01/2018 - 01/2017
2Neoplasms (Cancer)
01/2018 - 01/2018
1Immunoglobulin Light-chain Amyloidosis
01/2022
1Cardiac Arrhythmias (Arrythmia)
01/2021
1Multiple Myeloma
01/2018
1Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse)
01/2018
1Thrombotic Microangiopathies
11/2016
1Lipoid Nephrosis (Glomerulonephritis, Minimal Change)
11/2016
1Amyloidosis
11/2016
1Membranous Glomerulonephritis (Membranous Nephropathy)
11/2016

Drug/Important Bio-Agent (IBA)

5ibrutinibIBA
01/2021 - 01/2017
4Immunoglobulin M (IgM)IBA
01/2021 - 11/2016
2Hemoglobins (Hemoglobin)IBA
01/2021 - 05/2017
1pro-brain natriuretic peptide (1-76)IBA
01/2022
1A 419259IBA
01/2022
1daratumumabIBA
01/2022
1src-Family KinasesIBA
01/2022
1Interleukin-6 (Interleukin 6)IBA
01/2018
1Interleukin-10 (Interleukin 10)IBA
01/2018
1EverolimusFDA Link
05/2017

Therapy/Procedure

3Therapeutics
01/2022 - 05/2017
1Duration of Therapy
01/2022
1Drug Therapy (Chemotherapy)
01/2022